Dystonia associated with trazodone and sertraline.
Lewis
C F
CF
DeQuardo
J R
JR
Tandon
R
R
D015057:1-Naphthylamine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D000328:Adult; D018687:Antidepressive Agents, Second-Generation / Q000008:administration & dosage / Q000009:adverse effects*; D003866:Depressive Disorder / Q000175:diagnosis / Q000188:drug therapy*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D004421:Dystonia / Q000139:chemically induced* / Q000175:diagnosis; D006801:Humans; D008297:Male; D010148:Intractable Pain / Q000188:drug therapy* / Q000209:etiology; D017367:Selective Serotonin Reuptake Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*; D020280:Sertraline; D013313:Stress Disorders, Post-Traumatic / Q000175:diagnosis / Q000188:drug therapy*; D014196:Trazodone / Q000008:administration & dosage / Q000009:adverse effects*
D015057:1-Naphthylamine; D018687:Antidepressive Agents, Second-Generation; D017367:Selective Serotonin Reuptake Inhibitors; D020280:Sertraline; D014196:Trazodone